What is the recommended cephalexin (Keflex) dosing for cellulitis in adults and children, including adjustments for renal impairment or penicillin allergy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cephalexin (Keflex) Dosing for Cellulitis

For adults with non-purulent cellulitis, cephalexin 500 mg four times daily (QID) is the recommended dose, and for children, 25-50 mg/kg/day divided into 4 doses is appropriate. 1, 2

Adult Dosing

The IDSA 2014 guidelines clearly specify cephalexin 500 mg QID for methicillin-susceptible Staphylococcus aureus (MSSA) skin and soft tissue infections, noting it is appropriate for penicillin-allergic patients except those with immediate hypersensitivity reactions 1. The FDA label confirms the adult dosage range of 1-4 grams daily in divided doses, with 500 mg every 12 hours acceptable for uncomplicated skin infections, though more severe infections require higher or more frequent dosing 2.

Emerging evidence suggests higher doses may be beneficial for moderate-to-severe cellulitis:

  • A 2023 pilot RCT found that high-dose cephalexin (1000 mg QID) resulted in fewer treatment failures (3.2%) compared to standard-dose 500 mg QID (12.9%), though with more minor adverse effects 3
  • A 2022 pediatric study using high-dose oral cephalexin achieved an 89.7% success rate for moderate cellulitis, potentially reducing hospitalization 4
  • PK/PD modeling supports higher doses for optimizing target attainment, especially for S. aureus 5

Practical dosing algorithm:

  • Mild cellulitis: 500 mg QID (or 500 mg BID may be acceptable based on older data 6)
  • Moderate-to-severe cellulitis: Consider 1000 mg QID based on emerging evidence
  • Duration: 7-10 days typically, though IDSA guidelines don't specify exact duration for cellulitis

Pediatric Dosing

Standard dose: 25-50 mg/kg/day divided into 4 doses 1, 2

For skin and soft tissue infections, the total daily dose may be divided every 12 hours 2. In severe infections, dosage may be doubled 2. The high-dose pediatric approach (up to 75-100 mg/kg/day used for otitis media) has shown promise for moderate cellulitis 4.

Penicillin Allergy Considerations

Cephalexin is appropriate for penicillin-allergic patients EXCEPT those with immediate hypersensitivity reactions (anaphylaxis, urticaria, angioedema) 1.

This is a critical distinction:

  • Cephalexin has unique R1 and R2 side chains that minimize cross-reactivity with most penicillins 7
  • Cross-reactivity risk is slightly higher with amino-penicillins (amoxicillin/ampicillin) due to shared side chains 8
  • For documented type I allergies (anaphylaxis), consider alternative agents like clindamycin 300-450 mg QID or doxycycline 100 mg BID 1
  • For delayed-type reactions (rash), cephalexin is generally safe under clinical supervision 7

Alternative agents for true penicillin allergy with immediate hypersensitivity:

  • Clindamycin 300-450 mg QID (adults) or 20-30 mg/kg/day in 3 divided doses (children)
  • Doxycycline 100 mg BID (adults only, not for children <8 years)
  • Trimethoprim-sulfamethoxazole 1-2 double-strength tablets BID (though efficacy is less well-documented) 1

Renal Impairment

The FDA label states cephalexin should be administered with caution in markedly impaired renal function, with careful clinical observation and potentially lower doses than usually recommended 2. However, specific dose adjustments are not provided in the available evidence. In practice, standard dosing adjustments for cephalosporins apply, with dose reduction or interval extension based on creatinine clearance.

Important Caveats

  • MRSA coverage: Standard cephalexin does NOT cover MRSA. A 2017 RCT showed adding trimethoprim-sulfamethoxazole to cephalexin did not significantly improve cure rates for non-purulent cellulitis 9, supporting that streptococci remain the primary pathogen in typical cellulitis
  • Purulent infections: If abscess or purulent drainage is present, MRSA coverage is needed—cephalexin alone is insufficient 1
  • Treatment duration: While 7 days is commonly used, the IDSA guidelines don't specify exact duration for cellulitis; clinical response should guide therapy
  • Compliance: BID dosing may improve adherence and has shown comparable efficacy in some studies 6, 10, though QID remains the guideline-recommended frequency

References

Research

The Use of Perioperative Cephalexin in Penicillin Allergic Patients in Dermatologic Surgery: An Advisory Statement.

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.